Bovilis Ibr Marker Live - 20ml

For the active immunisation of cattle against
• Parainfluenza3 virus (PI3 virus), to reduce infections.
• Bovine Respiratory Syncytial Virus (BRSV) to reduce infection and clinical signs.
• Mannheimia (Pasteurella) haemolytica serotype A1, to reduce infection, mortality, clinical signs, lung lesions and bacterial invasion of the lung caused by serotypes A1 and A6. Cross-reactive immunity to the A6 serotype of M. haemolytica has been demonstrated in a challenge experiment under laboratory conditions after a primary course of vaccination.

Approximately two weeks after completion of the basic immunisation programme, the humoral immune response against BRS-Virus and PI3-Virus is at its highest level.

The duration of protective immunity has not been established in challenge experiments.

Dosage & Administration:
Vaccination dose: 5 ml by subcutaneous injection at the side of the neck.

For the active immunisation of cattle to reduce the intensity and duration of the clinical respiratory signs induced by an infection with BHV-1 and to reduce nasal excretion of field virus.

Dosage: a single dose of 2 ml reconstituted vaccine per animal.

For intranasal or intramuscular administration.

Aerosol spray containing oxytetracycline for use in cattle, sheep and pigs.

Active ingredient: Oxytetracycline

For the active immunisation of cattle to reduce the intensity and duration of the clinical respiratory signs induced by an infection with BHV-1 and to reduce nasal excretion of field virus.

Dosage: a single dose of 2 ml reconstituted vaccine per animal.
For intranasal or intramuscular administration.